
DocGo (DCGO) Stock Forecast & Price Target
DocGo (DCGO) Analyst Ratings
Bulls say
DocGo is projected to experience significant growth in their Mobile Health Services segment, with a potential contribution of $30 million from their recent acquisition of SteadyMD and further growth in virtual care services. However, a key concern is whether the company can decrease operating expenses enough to achieve their adjusted EBITDA target. Despite this challenge, the company has taken steps to reposition and improve their core medical transportation business, with a potential for $15-20 million in 2026 EBITDA. Overall, while uncertainties remain, there are positive indicators that DocGo is on the path to sustainable growth in the long term.
Bears say
DocGo is a healthcare provider that offers mobile health services, virtual care management, and transportation services. However, the company has struggled to scale its business and faces potential revenue headwinds in the future. Its current success is driven largely by COVID-related contracts, and there are risks involved due to government regulation and competition. While the company's business model and partnerships present opportunities for growth, it remains to be seen if they can effectively capitalize on them.
This aggregate rating is based on analysts' research of DocGo and is not a guaranteed prediction by Public.com or investment advice.
DocGo (DCGO) Analyst Forecast & Price Prediction
Start investing in DocGo (DCGO)
Order type
Buy in
Order amount
Est. shares
0 shares